BUSINESS● LOWOct 2 · Oct 2, 2026, 2:49 AM
Galderma, Switzerland's discreet Botox empire
Le Monde [en] · western europe
The dermatology company's market capitalization has doubled since its initial public offering in 2024. Despite recurring scandals, botulinum toxin injections are expected to rake in $13 billion this year.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS18m agoASML says it's getting order interest through 2030 as profit smashes expectationsCNBCBUSINESS18m agoMoney laundering failures land Bank of America with a $1.2 billion fineEuroNews [en]